Cigna, HCSC near deal on Medicare Advantage business: WSJ
The news comes less than a month after Cigna and Humana reportedly abandoned their merger.
Cigna, HCSC near deal on Medicare Advantage business: WSJ Read More »
Uncategorized
Walgreens nearly halfway through planned VillageMD clinic closures
The pharmacy chain announced last quarter that it would exit clinics in underperforming markets as it focuses on driving profitability in its healthcare segment.
Walgreens nearly halfway through planned VillageMD clinic closures Read More »
FDA warns providers not to buy or implant Synovo’s total hip system
Last year, the FDA sent a warning letter to Synovo after finding that its femoral resurfacing cup had been “significantly changed or modified.”
FDA warns providers not to buy or implant Synovo’s total hip system Read More »
Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
Cybin Inc. today outlined its recent positive Phase 2 CYB003 topline results in MDD and near-term milestones across its clinical-stage deuterated psilocybin and dDMT programs in development for the treatment of multiple mental health conditions.
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
Boehringer Ingelheim and 3T Biosciences (“3T”) today announced they have entered into a new strategic collaboration and licensing agreement focused on discovering and developing next-generation life-changing cancer immunotherapies.
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study
Medivir AB announced that Medivir’s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor.
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety
Alex Therapeutics and Vicore Pharma announced positive results of the COMPANION study, investigating the efficacy of Almee, a 9-week digital cognitive behavioral therapy intervention accessed through a smartphone or tablet.
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San Francisco, USA.
¿Qué había detrás del gigantismo de los dinosaurios?
En el asombroso reino de los dinosaurios, algunos gigantes caminaron desafiando las leyes de la naturaleza con su tamaño colosal. Desentrañemos los misterios detrás del gigantismo de algunos dinosaurios, explorando las teorías científicas más recientes que a …
¿Qué había detrás del gigantismo de los dinosaurios? Read More »